Brand Engagement Network Inc. (BNAI): Entry into a Material Definitive Agreement
Brand Engagement Network Inc. (BNAI) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 2 ex10-1.htm EX-10.1 Exhibit 10.1 SHAREHOLDER AGREEMENT AGREEMENT OF THE FOUNDING SHAREHOLDERS entered by Brand Engagement Network, Inc. (“BEN”) and INTERVENT INTERNATIONAL, LLC (“ INTERVENT ”), as the Founding Shareholders of INTERVENT Health AI, Inc. , (“ Health AI ”),
How this was made
The 30-second read
Why it matters
The agreement sets (i) equity issuance/allocations, (ii) a 3-person board structure with a neutral third director, and (iii) multi-year exclusivity plus licensing and reseller economics for the AI health-coaching platform.
Market read
Traders should focus on how the JV’s exclusivity/licensing and reserved share pools could affect future dilution, revenue visibility, and execution risk for BNAI’s Health AI initiative.
What to watch
The agreement reserves additional common shares and an LTIP pool at Health AI; dilution dynamics and milestone definitions for maintaining exclusivity are key but not quantified in the excerpt.
Background
The 8-K Item 1.01 attaches a shareholder agreement among Brand Engagement Network (BEN) and Intervent International for their Health AI joint venture.
Ticker impact
BNAI filed an 8-K disclosing a material definitive shareholder agreement for its Health AI joint venture, including equity issuance and exclusivity/licensing terms.
Near-term reaction is likely limited unless investors view the JV terms as meaningfully de-risking commercialization or increasing dilution/overhang; watch for follow-on financing or milestone-based exclusivity conditions.
This is a primary SEC disclosure (8-K) with concrete deal mechanics (board control, share allocations, exclusivity, revenue share), but the article provides no financial figures, guidance, or immediate revenue impact.
Market effects
Highlights a structured approach to AI health-coaching commercialization via exclusive IP/data licensing and reseller arrangements, which may influence how investors underwrite similar health-AI JV models.
North America commercialization focus is explicitly referenced, with additional geographies subject to mutual agreement.
Reseller language includes Mexico/Latin America, suggesting potential regional go-to-market expansion beyond the initial North America scope.
Counterpoint
Exclusivity and revenue-share terms may constrain Health AI’s flexibility and create milestone-driven failure risk; without disclosed traction, the market may discount the agreement.
Key entities
- issuerBrand Engagement Network, Inc.
Filed the 8-K disclosing the shareholder agreement for the Health AI joint venture and related licensing/exclusivity terms.
- counterpartyINTERVENT INTERNATIONAL, LLC
Co-founder/partner in the Health AI joint venture; provides IP/data and participates in board designation and equity allocations.
- joint_ventureINTERVENT Health AI, Inc.
The entity created for developing and commercializing the “Stand-Alone AI Health Coach” product offerings; subject of the shareholder agreement.
